Top 10 Biotech Angel Investors in Denmark in May 2026

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Investment focus

Biotechnology, Robotics, Biopharma
Pre-Seed, Series A, Seed
Denmark

Portfolio highlights

Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.

Show all investments...

Nicholas Francis is Co-founder at framebunker

Investment focus

SaaS, Robotics, Software
Seed, Series A
Denmark, United States

Portfolio highlights

Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
Reshape Biotech — Fully digital microbiology developed by Reshape Biotech

Show all investments...

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

Investment focus

Biotechnology, Food and Beverage, Plant-Based Foods
Seed, Pre-Seed
Italy, Denmark

Portfolio highlights

Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.

Show all investments...

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Investment focus

Cannabis, Health Care, Biotechnology
Post-IPO Equity, Seed, Pre-Seed
Canada, United States, Denmark

Portfolio highlights

Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
MindMed — MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. Learn more about our medicines and therapies today.
Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.

Show all investments...

Steen Riisgaard

Investment focus

Life Science, Therapeutics, Biotechnology
Pre-Seed
Denmark

Portfolio highlights

Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.

Show all investments...

Peter Sandberg is a Co-Founder of Nordic Secondary Fund, and a venture partner at Startup Wise Guys. He has extensive experience as a Business Angel, Asset Management and Wealth Management

Investment focus

Internet, Mobile Payments, Artificial Intelligence
Angel, Pre-Seed, Secondary Market
Denmark, Kenya, Estonia

Portfolio highlights

TRAPMINE — TRAPMINE Endpoint Protection Platform provides fool-proof defense against malware, exploit attempts, file-less malware, ransomware and other forms of targeted attacks.Unlike traditional detection-based approaches like legacy antivirus, TRAPMINE combines proven and innovative technologies such as deep learning, behavior monitoring, endpointdeception and anti-exploit techniques to block cyber threats dead in their tracks. TRAPMINE's easy-deploy and lightweight solution comes with a comfortable built-in security console, at a price/performance ratio unmatchable even by the biggest names in Palo Alto.Why TRAPMINE?Cyber criminals target companies of all sizes from every industry, seeking anything that might be of value. Antivirus and other traditional security solutions are no longer efficient to protect organizations from attacks by today’s modern cyber threat actors. That’s why we founded TRAPMINE. TRAPMINE is created to solve the malware problem for all organizations at a reasonable price.
Colibo A/S — Use Colibo's intranet software as your enterprise collaboration platform to increase productivity, drive employee engagement and better internal communications.
November First — November First - Betalingsplatform til alle virksomheder

Show all investments...

Mads Ingwar is the Co-Founder at Invert. He attended DTU - Technical University of Denmark.

Investment focus

Robotics, Biotechnology, Industrial Automation
Seed
Denmark

Portfolio highlights

Reshape Biotech — Fully digital microbiology developed by Reshape Biotech

Show all investments...

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Germany

Portfolio highlights

Nexcade — Bringing intelligent automation to Freight Forwarding. Nexcade builds agents that meet forwarders where they work today- cutting through noise, accelerating descisions, and helping teams win more business.
Forgent AI — Forgent uses AI agents to draft tender proposals, find opportunities and coordinate teams.
Interface — Interface is an AI-native Document Management System for High Hazard Industries.

Show all investments...

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Investment focus

Software, Gaming, Information Technology
Seed, Series A, Funding Round
United States, Denmark, Finland

Portfolio highlights

IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
Flow Engineering — Requirements management, made collaborative

Show all investments...